Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Jacobson

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Annals of Internal Medicine|May 1, 1989
Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trialK S Erlich, M A Jacobson, J E Koehler, et al.
Nature Medicine|August 13, 1998
Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1K V Komanduri, M N Viswanathan, E D Wieder, et al.
Gene|December 28, 1989
Expression and secretion of biologically active echistatin in Saccharomyces cerevisiaeM A Jacobson, F M Forma, R F Buenaga, et al.
DNA and Cell Biology|July 1, 1990
The uses of computer-aided signal peptide selection and polymerase chain reaction in gene construction and expression of secreted proteinsB L Daugherty, S M Zavodny, A B Lenny, et al.
AIDS (London, England)|February 10, 1998
Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study GroupD R Kuritzkes, D Parenti, D J Ward, et al.
AIDS (London, England)|October 29, 1998
Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997C D Holtzer, M A Jacobson, W K Hadley, et al.
The Journal of Infectious Diseases|June 1, 1989
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidineM A Jacobson, D I Abrams, P A Volberding, et al.
The Journal of Infectious Diseases|April 11, 2001
Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapyM A Jacobson, R Schrier, J M McCune, et al.
BMJ (Clinical Research Ed.)|January 12, 1991
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudineM A Jacobson, P Bacchetti, A Kolokathis, et al.
Biochemistry|July 18, 1995
Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptorsK A Jacobson, C Guay-Broder, P J van Galen, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Annals of Internal Medicine|May 1, 1989
Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trialK S Erlich, M A Jacobson, J E Koehler, et al.
Nature Medicine|August 13, 1998
Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1K V Komanduri, M N Viswanathan, E D Wieder, et al.
Gene|December 28, 1989
Expression and secretion of biologically active echistatin in Saccharomyces cerevisiaeM A Jacobson, F M Forma, R F Buenaga, et al.
DNA and Cell Biology|July 1, 1990
The uses of computer-aided signal peptide selection and polymerase chain reaction in gene construction and expression of secreted proteinsB L Daugherty, S M Zavodny, A B Lenny, et al.
AIDS (London, England)|February 10, 1998
Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study GroupD R Kuritzkes, D Parenti, D J Ward, et al.
AIDS (London, England)|October 29, 1998
Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997C D Holtzer, M A Jacobson, W K Hadley, et al.
The Journal of Infectious Diseases|June 1, 1989
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidineM A Jacobson, D I Abrams, P A Volberding, et al.
The Journal of Infectious Diseases|April 11, 2001
Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapyM A Jacobson, R Schrier, J M McCune, et al.
BMJ (Clinical Research Ed.)|January 12, 1991
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudineM A Jacobson, P Bacchetti, A Kolokathis, et al.
Biochemistry|July 18, 1995
Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptorsK A Jacobson, C Guay-Broder, P J van Galen, et al.
Pageof 15